Injectable Polypeptide Hydrogel Depot System for Assessment of the Immune Response–Inducing Efficacy of Sustained Antigen Release Alone

Daisuke Asai, Tadashi Fukuda, Kazunori Morokuma, Daiki Funamoto, Yuko Yamaguchi, Takeshi Mori, Yoshiki Katayama, Keigo Shibayama, Hideki Nakashima

研究成果: ジャーナルへの寄稿記事

抄録

Vaccines typically contain an antigen, delivery system (vehicle), and adjuvant, all of which contribute to inducing a potent immune response. Consequently, design of new vaccines is difficult, because the contributions and interactions of these components are difficult to distinguish. Here, it is aimed to develop an easy-to-use, non-immunogenic, injectable depot system for sustained antigen release that will be suitable for assessing the efficacy of prolonged antigen exposure per se for inducing an immune response. This should mimic real-life infections. Recombinant elastin-like polypeptides with periodic cysteine residues (cELPs) are selected, which reportedly show little or no immunogenicity, as carriers and tetanus toxoid (Ttd) as an antigen. After subcutaneous injection of the mixture, cELP rapidly forms a disulfide cross-linked hydrogel in situ, within which Ttd is physically incorporated, affording a biodegradable antigen depot. A series of Ttd-containing hydrogels is examined. A single injection induces high levels of tetanus antibody with high avidity for at least 20 weeks in mice. The chain length of cELP proves critical, whereas differences in hydrophobicity has little effect, although hydrophilic cELPs are more rapidly biodegraded. This system's ability to distinguish the contribution of sustained antigen release to antibody induction should be helpful for rational design of next-generation vaccines.

元の言語英語
記事番号1900167
ジャーナルMacromolecular Bioscience
19
発行部数10
DOI
出版物ステータス出版済み - 10 1 2019

Fingerprint

Hydrogel
Polypeptides
Antigens
Hydrogels
Immune System
Peptides
Tetanus Toxoid
Injections
Vaccines
Antibodies
Elastin
Tetanus
Subcutaneous Injections
Hydrophobicity
Hydrophobic and Hydrophilic Interactions
Chain length
Disulfides
Cysteine
Infection

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Biomaterials
  • Polymers and Plastics
  • Materials Chemistry

これを引用

Injectable Polypeptide Hydrogel Depot System for Assessment of the Immune Response–Inducing Efficacy of Sustained Antigen Release Alone. / Asai, Daisuke; Fukuda, Tadashi; Morokuma, Kazunori; Funamoto, Daiki; Yamaguchi, Yuko; Mori, Takeshi; Katayama, Yoshiki; Shibayama, Keigo; Nakashima, Hideki.

:: Macromolecular Bioscience, 巻 19, 番号 10, 1900167, 01.10.2019.

研究成果: ジャーナルへの寄稿記事

Asai, Daisuke ; Fukuda, Tadashi ; Morokuma, Kazunori ; Funamoto, Daiki ; Yamaguchi, Yuko ; Mori, Takeshi ; Katayama, Yoshiki ; Shibayama, Keigo ; Nakashima, Hideki. / Injectable Polypeptide Hydrogel Depot System for Assessment of the Immune Response–Inducing Efficacy of Sustained Antigen Release Alone. :: Macromolecular Bioscience. 2019 ; 巻 19, 番号 10.
@article{a5deb5a3163b471a97bee5201289d4b1,
title = "Injectable Polypeptide Hydrogel Depot System for Assessment of the Immune Response–Inducing Efficacy of Sustained Antigen Release Alone",
abstract = "Vaccines typically contain an antigen, delivery system (vehicle), and adjuvant, all of which contribute to inducing a potent immune response. Consequently, design of new vaccines is difficult, because the contributions and interactions of these components are difficult to distinguish. Here, it is aimed to develop an easy-to-use, non-immunogenic, injectable depot system for sustained antigen release that will be suitable for assessing the efficacy of prolonged antigen exposure per se for inducing an immune response. This should mimic real-life infections. Recombinant elastin-like polypeptides with periodic cysteine residues (cELPs) are selected, which reportedly show little or no immunogenicity, as carriers and tetanus toxoid (Ttd) as an antigen. After subcutaneous injection of the mixture, cELP rapidly forms a disulfide cross-linked hydrogel in situ, within which Ttd is physically incorporated, affording a biodegradable antigen depot. A series of Ttd-containing hydrogels is examined. A single injection induces high levels of tetanus antibody with high avidity for at least 20 weeks in mice. The chain length of cELP proves critical, whereas differences in hydrophobicity has little effect, although hydrophilic cELPs are more rapidly biodegraded. This system's ability to distinguish the contribution of sustained antigen release to antibody induction should be helpful for rational design of next-generation vaccines.",
author = "Daisuke Asai and Tadashi Fukuda and Kazunori Morokuma and Daiki Funamoto and Yuko Yamaguchi and Takeshi Mori and Yoshiki Katayama and Keigo Shibayama and Hideki Nakashima",
year = "2019",
month = "10",
day = "1",
doi = "10.1002/mabi.201900167",
language = "English",
volume = "19",
journal = "Macromolecular Bioscience",
issn = "1616-5187",
publisher = "Wiley-VCH Verlag",
number = "10",

}

TY - JOUR

T1 - Injectable Polypeptide Hydrogel Depot System for Assessment of the Immune Response–Inducing Efficacy of Sustained Antigen Release Alone

AU - Asai, Daisuke

AU - Fukuda, Tadashi

AU - Morokuma, Kazunori

AU - Funamoto, Daiki

AU - Yamaguchi, Yuko

AU - Mori, Takeshi

AU - Katayama, Yoshiki

AU - Shibayama, Keigo

AU - Nakashima, Hideki

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Vaccines typically contain an antigen, delivery system (vehicle), and adjuvant, all of which contribute to inducing a potent immune response. Consequently, design of new vaccines is difficult, because the contributions and interactions of these components are difficult to distinguish. Here, it is aimed to develop an easy-to-use, non-immunogenic, injectable depot system for sustained antigen release that will be suitable for assessing the efficacy of prolonged antigen exposure per se for inducing an immune response. This should mimic real-life infections. Recombinant elastin-like polypeptides with periodic cysteine residues (cELPs) are selected, which reportedly show little or no immunogenicity, as carriers and tetanus toxoid (Ttd) as an antigen. After subcutaneous injection of the mixture, cELP rapidly forms a disulfide cross-linked hydrogel in situ, within which Ttd is physically incorporated, affording a biodegradable antigen depot. A series of Ttd-containing hydrogels is examined. A single injection induces high levels of tetanus antibody with high avidity for at least 20 weeks in mice. The chain length of cELP proves critical, whereas differences in hydrophobicity has little effect, although hydrophilic cELPs are more rapidly biodegraded. This system's ability to distinguish the contribution of sustained antigen release to antibody induction should be helpful for rational design of next-generation vaccines.

AB - Vaccines typically contain an antigen, delivery system (vehicle), and adjuvant, all of which contribute to inducing a potent immune response. Consequently, design of new vaccines is difficult, because the contributions and interactions of these components are difficult to distinguish. Here, it is aimed to develop an easy-to-use, non-immunogenic, injectable depot system for sustained antigen release that will be suitable for assessing the efficacy of prolonged antigen exposure per se for inducing an immune response. This should mimic real-life infections. Recombinant elastin-like polypeptides with periodic cysteine residues (cELPs) are selected, which reportedly show little or no immunogenicity, as carriers and tetanus toxoid (Ttd) as an antigen. After subcutaneous injection of the mixture, cELP rapidly forms a disulfide cross-linked hydrogel in situ, within which Ttd is physically incorporated, affording a biodegradable antigen depot. A series of Ttd-containing hydrogels is examined. A single injection induces high levels of tetanus antibody with high avidity for at least 20 weeks in mice. The chain length of cELP proves critical, whereas differences in hydrophobicity has little effect, although hydrophilic cELPs are more rapidly biodegraded. This system's ability to distinguish the contribution of sustained antigen release to antibody induction should be helpful for rational design of next-generation vaccines.

UR - http://www.scopus.com/inward/record.url?scp=85070914418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070914418&partnerID=8YFLogxK

U2 - 10.1002/mabi.201900167

DO - 10.1002/mabi.201900167

M3 - Article

AN - SCOPUS:85070914418

VL - 19

JO - Macromolecular Bioscience

JF - Macromolecular Bioscience

SN - 1616-5187

IS - 10

M1 - 1900167

ER -